USPH US Physical Therapy
- 107.970
- +1.570+1.48%
- 107.970
- 0.0000.00%
US Physical Therapy News
Form 144 | US Physical Therapy(USPH.US) Director Proposes to Sell 268.92K in Common Stocks
SEC FILLINGS DISCLOSED/ May 15, $US Physical Therapy(USPH.US)$ Director EDWARD KUNTZ intends to sell 2,500 shares of its common stock on May 15, with a total market value of approximately $268.92K.
US Physical Therapy(USPH.US) Officer Sells US$260.55K in Common Stock
$US Physical Therapy(USPH.US)$ Officer Williams Eric Joseph sold 2,500 shares of common stock on May 10, 2024 at an average price of $104.22 for a total value of $260.55K.Source: Announcement What is
US Physical Therapy(USPH.US) Officer Sells US$181.81K in Common Stock
$US Physical Therapy(USPH.US)$ Officer REEVE GRAHAM D. sold 1,724 shares of common stock on May 10, 2024 at an average price of $105.46 for a total value of $181.81K.Source: Announcement What is state
Form 144 | US Physical Therapy(USPH.US) Officer Proposes to Sell 260.55K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $US Physical Therapy(USPH.US)$ Officer ERIC WILLIAMS intends to sell 2,500 shares of its common stock on May 10, with a total market value of approximately $260.55K.
Form 144 | US Physical Therapy(USPH.US) Insider Proposes to Sell 181.81K in Common Stocks
SEC FILLINGS DISCLOSED/ May 10, $US Physical Therapy(USPH.US)$ Insider Graham Reeve intends to sell 1,724 shares of its common stock on May 10, with a total market value of approximately $181.81K. G
U.S. Physical Therapy, Inc. (NYSE:USPH) Q1 2024 Earnings Call Transcript
US Physical Therapy Is Maintained at Outperform by Barrington Research
US Physical Therapy Is Maintained at Outperform by Barrington Research
Barrington Research Maintains Outperform on US Physical Therapy, Maintains $122 Price Target
Barrington Research analyst Michael Petusky maintains US Physical Therapy with a Outperform and maintains $122 price target.
Analysts' Top Healthcare Picks: US Physical Therapy (USPH), Exact Sciences (EXAS)
Buy Rating for US Physical Therapy: Strong Performance and Positive Growth Outlook
Q1 2024 US Physical Therapy Inc Earnings Call
US Physical Therapy | 10-Q: Quarterly report
U.S. Physical Therapy, Inc. (USPH) Q1 2024 Earnings Call Transcript
U.S. Physical Therapy, Inc. (USPH) Q1 2024 Earnings Call Transcript
U.S. Physical Therapy Sees 2024 Adj. EBITDA $82.5M-$87.5M
U.S. Physical Therapy Sees 2024 Adj. EBITDA $82.5M-$87.5M
US Physical Therapy Q1 2024 Adj EPS $0.51 Misses $0.56 Estimate, Sales $155.675M Beat $153.366M Estimate
US Physical Therapy (NYSE:USPH) reported quarterly earnings of $0.51 per share which missed the analyst consensus estimate of $0.56 by 8.93 percent. This is a 13.56 percent decrease over earnings of $
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Reports Q1 EPS $0.46, Vs. Street Est of $0.56
05:03 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (USPH) U.S. PHYSICAL THERAPY Reports Q1 EPS $0.46, vs. Street Est of $0.56
Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q1 Revenue $155.7M, Vs. Street Est of $153.4M
05:02 PM EDT, 05/07/2024 (MT Newswires) -- Earnings Flash (USPH) U.S. PHYSICAL THERAPY Posts Q1 Revenue $155.7M, vs. Street Est of $153.4M
Press Release: U.S. Physical Therapy Reports First Quarter 2024 Results
U.S. Physical Therapy Reports First Quarter 2024 Results Management Raises Full Year 2024 Guidance HOUSTON--(BUSINESS WIRE)--May 07, 2024-- U.S. Physical Therapy, Inc. ("USPH" or the "Company") (NY
US Physical Therapy 1Q Rev $155.7M >USPH
US Physical Therapy 1Q Rev $155.7M >USPH
A Look At The Intrinsic Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)
Key Insights U.S. Physical Therapy's estimated fair value is US$113 based on 2 Stage Free Cash Flow to Equity With US$105 share price, U.S. Physical Therapy appears to be trading close to its estima
Analysis
Price Target
No Data
